|
acute myeloid leukemia |
|
ARID1B
|
Causal |
|
Open Targets |
|
|
ATM
|
Causal |
|
Open Targets |
|
|
BCOR
|
Causal |
|
Open Targets |
|
|
CALR
|
Causal |
|
Open Targets |
|
|
CBL
|
Causal |
|
Open Targets |
|
|
CEBPA
|
Causal |
|
ClinGen, Open Targets |
|
|
DNMT3A
|
Causal |
|
Open Targets |
|
|
ELF4
|
Causal |
|
Open Targets |
—
|
|
ETV6
|
Causal |
|
Open Targets |
|
|
FLT3
|
Causal |
|
Open Targets |
|
|
FOXP1
|
Causal |
|
Open Targets |
|
|
GATA2
|
Causal |
|
Open Targets |
|
|
IDH1
|
Causal |
|
Open Targets |
|
|
JAK2
|
Causal |
|
Open Targets |
|
|
KIT
|
Causal |
|
Open Targets |
|
|
KRAS
|
Causal |
|
Open Targets |
|
|
MYC
|
Causal |
|
Open Targets |
|
|
NF1
|
Causal |
|
Open Targets |
|
|
NPM1
|
Causal |
|
Open Targets |
|
|
NRAS
|
Causal |
|
Open Targets |
|
|
NSD1
|
Causal |
|
Open Targets |
|
|
POT1
|
Causal |
|
Open Targets |
|
|
SF3B1
|
Causal |
|
Open Targets |
|
|
SRSF2
|
Causal |
|
Open Targets |
|
|
TERT
|
Causal |
|
Open Targets |
|
|
TP53
|
Causal |
|
Open Targets |
|